FDA Issues Emergency Approval To Lilly's Arthritis Drug With Remdesivir For COVID-19 Treatment

RTT News

by Super Admin 39 Views

The U.S. Food and Drug Administration issued an emergency use authorization for Eli Lilly and Co.'s (LLY) rheumatoid arthritis drug baricitinib, in combination with Gilead Sciences' (GILD) remdesivir, to treat COVID-19 patients.